Referências

1. Das Pradhan A, 2022, NEW ENGL J MED, V387, P1923, DOI 10.1056/NEJMoa2210645
2. Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
3. Ference BA, 2019, JAMA-J AM MED ASSOC, V321, P364, DOI 10.1001/jama.2018.20045
4. Fruchart JC, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0864-7
5. Ginsberg HN, 2021, EUR HEART J, V42, P4791, DOI 10.1093/eurheartj/ehab551
6. Hegele RA, 2014, LANCET DIABETES ENDO, V2, P655, DOI 10.1016/S2213-8587(13)70191-8
7. Lee SJ, 2023, EUR J PREV CARDIOL, V30, P1166, DOI [10.1093/eurjpc/zwad070, 10.1093/eurjpc/zwad036]
8. Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1093/eurheartj/ehz455, 10.1016/j.atherosclerosis.2019.08.014]
9. Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038
10. Nicholls SJ, 2018, JAMA CARDIOL, V3, P806, DOI 10.1001/jamacardio.2018.2112
11. Packard CJ, 2022, CURR ATHEROSCLER REP, V24, P133, DOI 10.1007/s11883-022-00994-z
12. Quispe R, 2021, EUR HEART J, V42, P4324, DOI 10.1093/eurheartj/ehab432
13. Sampson M, 2020, JAMA CARDIOL, V5, P540, DOI 10.1001/jamacardio.2020.0013
14. Santos RD, 2019, J CLIN ENDOCR METAB, V104, P4114, DOI 10.1210/jc.2019-00845
15. Santos RD, 2017, LANCET DIABETES ENDO, V5, P489, DOI 10.1016/S2213-8587(17)30101-8
16. Tsimikas S, 2018, J AM COLL CARDIOL, V71, P177, DOI 10.1016/j.jacc.2017.11.014
17. Varbo A, 2021, EUR HEART J, V42, P4833, DOI 10.1093/eurheartj/ehab293
18. Varbo A, 2013, CIRCULATION, V128, P1298, DOI 10.1161/CIRCULATIONAHA.113.003008
19. Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026
20. Zheng KH, 2020, ATHEROSCLEROSIS, V311, P13, DOI 10.1016/j.atherosclerosis.2020.08.004